Fractalkine as an important target of aspirin in the prevention of atherogenesis : Editorial to: "Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice" by H. Liu et al

Cardiovasc Drugs Ther. 2010 Feb;24(1):1-3. doi: 10.1007/s10557-009-6213-4.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Apolipoproteins E / genetics
  • Aspirin / pharmacology*
  • Aspirin / therapeutic use*
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology*
  • Atherosclerosis / prevention & control*
  • Chemokine CX3CL1 / metabolism*
  • Chemokines / metabolism
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use
  • Humans
  • Mice
  • Mice, Knockout
  • Monocytes / metabolism
  • Monocytes / pathology
  • Receptors, Chemokine / metabolism

Substances

  • Apolipoproteins E
  • Chemokine CX3CL1
  • Chemokines
  • Cx3cl1 protein, mouse
  • Cyclooxygenase Inhibitors
  • Receptors, Chemokine
  • Aspirin